Key facts
- It has raised $19.6M across 6 recorded rounds; the latest was Accelerator/Incubator in Jan 2020.
- Celmatix has filed 6 Form Ds with the SEC since 2011, most recently Apr 2016 ($4.8M sold to 1 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·Watchlist + deal alerts for Celmatix
Create free account
No card required
Funding rounds
6 roundsJan 2020Accelerator/Incubator—▮
About Celmatix
- Industry
- Drug Discovery
PA Mark — not yet priced
Celmatix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Celmatix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Celmatix in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.